TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 44 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $53,000 | +381.8% | 56,000 | +366.7% | 0.00% | – |
| Q3 2019 | $11,000 | -77.6% | 12,000 | -77.4% | 0.00% | – |
| Q1 2019 | $49,000 | -94.5% | 53,000 | -94.7% | 0.00% | -100.0% |
| Q1 2018 | $890,000 | -59.8% | 1,000,000 | -50.5% | 0.01% | -58.3% |
| Q4 2016 | $2,216,000 | -63.3% | 2,021,000 | -47.5% | 0.01% | -64.7% |
| Q4 2015 | $6,046,000 | +237.2% | 3,852,000 | +191.4% | 0.03% | +240.0% |
| Q3 2015 | $1,793,000 | +248.8% | 1,322,000 | +251.6% | 0.01% | +233.3% |
| Q4 2014 | $514,000 | -73.9% | 376,000 | -79.7% | 0.00% | -76.9% |
| Q4 2013 | $1,970,000 | – | 1,855,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |